Home  |  繁體  |  簡体
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Annual Report


Announcements and Notices - Announcement Pursuant to Rule 3.8 of the Takeovers Code


Joint Announcement - (1) Proposed Privatization of Bloomage Biotechnology Corporation Limited by Grand Full Development Limited by Way of A Scheme of Arrangement (under Section 86 of the Companies Law) and (2) Proposed withdrawal of Listing of the Shares of Bloomage Biotechnology Corporation Limited - Extension of Time for Despatch of the Scheme Document


Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2017

HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd